Cel Sci Corporation (CVM)

[PlanTrader]

@lightrock, What does that have to do with whether they've provided any data on % OSI for the overall study? You claimed it helps to some extent for the whole trial population... well, how much? And where did you get that info? Did they provide that and I missed it, or did you avoid my question?

And while 155K may be the non-chemo population overall, we've been given no other info to support the validity of the claim as of yet. Did you miss that? And who gets it, seeing as how the need for chemo isn't known until after surgery? Again, total lack of context provided so far.

With the info we have so far, the question is... will the FDA approve this based on the concept that everyone should (or can choose) to take MK while knowing that only 40% will benefit from it. I'm not scoffing at that idea, since any benefit to anyone is great. But it's not as simplistic as that w/out being able to see the other info.